The evaluation of patients with mild to moderate bleeding disorder can be frustratingly
unproductive. Patients frequently present with bothersome symptoms, such as recurrent
epistaxis, easy bruising or menorrhagia, undergo a battery of investigations, only
to reveal normal results. Such patients also may demonstrate a family history or have
had abnormal bleeding after surgical procedures. Comprehensive laboratory-based bleeding
evaluations of patients with suspected bleeding disorders are inconvenient for the
patient, are expensive in some healthcare settings, may be difficult to access, and
are extraordinarily complex to explain to patients. Availability of an easy to use
clinically-based tool with high predictive value for the presence of a laboratory
confirmed bleeding disorder would greatly simplify the evaluation of such patients
and allow clinicians to prioritize those patients requiring laboratory investigation.
This could further simplify clinical monitoring and, potentially, treatment of such
patients.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
Gebhart J, Hofer S, Kaider A, et. al. The discriminatory power of bleeding assessment tools in adult patients with a mild to moderate bleeding tendency. Eur J Internal Med, 10.1016/j.ejim.2020.04.023.
- The discriminant power of bleeding history for the diagnosis of type1 von Willebrand disease: an international, multi-center study.J Thromb Haemost. 2005; 3: 2619-2626
- ISTH/SSC bleeding assessment tool: a standardised questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.J Thromb Haemost. 2010; 8: 2063-2065
- Fundamentals for a systematic approach to mild and moderate inherited bleeding disorders: an EHA consensus report.HemaSphere. 2019; 3: e286
- High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: results form the Vienna bleeding biobank (VIBB).Haemophilia: Off J World Feder Haemophilia. 2018; 24: 405-413
- High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls.Haematologica. 2007; 92: 357-365
Article info
Publication history
Published online: June 07, 2020
Accepted:
May 14,
2020
Received:
May 11,
2020
Identification
Copyright
© 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.